Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System

NCT00056628 is registered in ClinicalTrials.gov with Eunoe as lead sponsor.

NCT NCT00056628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00056628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System
Lead sponsor
Eunoe
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2001
Completion date
October 31, 2004
Enrollment
250
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease